Skip to main content

Topiramate (International)

In the US, Topiramate (topiramate systemic) is a member of the drug class carbonic anhydrase inhibitor anticonvulsants and is used to treat Bipolar Disorder, Borderline Personality Disorder, Bulimia, Diabetic Peripheral Neuropathy, Epilepsy, Fibromyalgia, Lennox-Gastaut Syndrome, Migraine, Migraine Prevention, Seizure Prevention, Seizures, Smoking Cessation, Tourette's Syndrome, Trigeminal Neuralgia, Vulvodynia and Weight Loss (Obesity/Overweight).

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AX11

CAS registry number (Chemical Abstracts Service)

0097240-79-4

Chemical Formula

C12-H21-N-O8-S

Molecular Weight

339

Therapeutic Category

Antiepileptic agent

Chemical Name

2,3:4,5-Di-O-Isopropylidene-β-D-fructopyranose sulfamate

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs